These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9365 related articles for article (PubMed ID: 16708643)
1. [BRAF gene mutation in thyroid cancer]. Kopczyńska E; Junik R; Tyrakowski T Pol Merkur Lekarski; 2006 Feb; 20(116):210-3. PubMed ID: 16708643 [TBL] [Abstract][Full Text] [Related]
2. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632 [TBL] [Abstract][Full Text] [Related]
3. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
4. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240 [TBL] [Abstract][Full Text] [Related]
6. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
7. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Soares P; Trovisco V; Rocha AS; Lima J; Castro P; Preto A; Máximo V; Botelho T; Seruca R; Sobrinho-Simões M Oncogene; 2003 Jul; 22(29):4578-80. PubMed ID: 12881714 [TBL] [Abstract][Full Text] [Related]
9. BRAF mutations in papillary carcinomas of the thyroid. Fukushima T; Suzuki S; Mashiko M; Ohtake T; Endo Y; Takebayashi Y; Sekikawa K; Hagiwara K; Takenoshita S Oncogene; 2003 Sep; 22(41):6455-7. PubMed ID: 14508525 [TBL] [Abstract][Full Text] [Related]
10. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433 [TBL] [Abstract][Full Text] [Related]
11. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863 [TBL] [Abstract][Full Text] [Related]